NASDAQ Composite opens in less than one hour and Catalyst Pharmaceuticals’s pre-market value is already 2.01% up.

The last session, NASDAQ Composite finished with Catalyst Pharmaceuticals dropping 1.13% to $3.49. NASDAQ Composite fell 0.87% to $12,998.50, after two sequential sessions in a row of losses, on what was a somewhat rough trend exchanging session.

Catalyst Pharmaceuticals’s last close was $3.53, 51.29% under its 52-week high of $5.28.

Catalyst Pharmaceuticals’s Sales

Catalyst Pharmaceuticals’s sales growth is 0.8% for the current quarter and 5.5% for the next. The company’s growth estimates for the current quarter is 12.5% and a drop 20% for the next.

Volatility

Catalyst Pharmaceuticals’s last day, last week, and last month’s average volatility was a positive 0.28%, a negative 0.11%, and a negative 0.39%, respectively.

Catalyst Pharmaceuticals’s last day, last week, and last month’s high and low average amplitude percentage was 3.76%, 3.98%, and 4.40%, respectively.

LEAVE A REPLY

Please enter your comment!
Please enter your name here